Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity

Journal of Lipid Research

Volumn 40, Issue 1, 1999, Pages 59-69

  Peelman, F ^a   Verschelde, J L ^b   Vanloo, B ^a   Ampe, C ^b   Labeur, C ^a   Tavernier, J ^b   Vandekerckhove, J ^b   Rosseneu, M ^a  

^a GHENT UNIVERSITY   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Enzymatic activity; Lecithin:cholesterol acyltransferase; Lipoproteins; Mutants; Reverse cholesterol transport; Structure

Indexed keywords

PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TRIACYLGLYCEROL LIPASE;

ARTICLE; CHOLESTEROL TRANSPORT; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME STRUCTURE; HUMAN; HYPOLIPOPROTEINEMIA; LIPOPROTEIN METABOLISM; MOLECULAR MODEL; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN INTERACTION; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; CATALYTIC DOMAIN; CONSERVED SEQUENCE; HUMANS; LECITHIN ACYLTRANSFERASE DEFICIENCY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHENOTYPE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; POINT MUTATION; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0032920653     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Glomset, J. A. 1962. The mechanism of the plasma cholesterol esterification reaction : plasma fatty acid transferase. Biochim. Biophys. Acta. 65: 128-135.
2. Jonas, A. 1991. Lecithin:cholesterol acyltransferase in the metabolism of high-density lipoproteins. Biochim. Biophys. Acta. 1084; 205-220.
3. McLean, J., C. Fielding, D. Drayna, H. Dieplinger, B. Braer, W. Kohr, W. Henzel, and R. Lawn. 1986. Cloning and expression of human lecithin:cholesterol acyltransferase cDNA. Proc. Natl. Acad. Sci. USA. 83: 2335-2339.
4. McLean, J., K. Wion, W. Drayna, C. Fielding, and R. Lawn. 1986. Human lecithin:cholesterol acyltransferase gene: complete gene sequence and sites of expression. Nucleic Acids Res. 14: 9397-9406.
5. Kuivenhoven, J. A., H. Pritchard, J. Hill, J. Frohlich, G. Assmann, and J. Kastelein. 1997. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J. Lipid Res. 38: 191-205.
6. Norum, K. R., and E. Gjone. 1967. Familial plasma lecithin:cholesterol acyltransferase deficiency. Biochemical study of a new inborn error of metabolism. Scand. J. Clin. Lab. Invest. 20: 231-243.
7. Glomset, J. A., G. Assmann, E. Gjone, and K. R. Norum. 1995. Lecithin:cholesterol acyltransferase deficiency and fish-eye disease. In The Metabolic and Molecular Bases of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill Book Co., New York. 1933-1951.
8. Carlson, L. A., and B. Philipson. 1979. Fish-eye disease. New familial condition with massive corneal opacities and dyslipoproteinemia. Lancet, ii: 921-924.
9. Assmann, G., A. Von Eckardstein, and H. B. Brewer. 1995. Familial high density lipoprotein deficiency. In The Metabolic and Molecular Bases of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill Book Co., New York. 2053-2072.
10. Schindler, P. A., C. Settiner, X. Collet, C. J. Fielding, and A. L. Burlingame. 1995. Site-specific detection and structural characterisation of the glycosylation of human plasma proteins lecithin:cholesterol acyltransferase and apolipoprotein D using HPLC/electrospray mass spectrometry and sequential glycosidase detection. Protein Sci. 4: 791-803.
11. Jauhiainen, M., and P. J. Dolphin. 1986. Human plasma lecithin:cholesterol acyltransferase. An elucidation of the catalytic mechanism. J. Biol. Chem. 261: 7032-7043.
12. Francone, O. L., and C. J. Fielding. 1991. Structure-function relationships of human lecithin cholesterol acyltransferase. Site directed mutagenesis at serine residues 181 and 216. Biochemistry. 30: 10074-10077.
13. Peelman, F., N. Vinaimont, A. Verhee, B. Vanloo, J. L. Verschelde, C. Labeur, S. Séguret-Macé, N. Duverger, G. Hutchinson, J. Vandekerckhove, J. Tavernier, and M. Rosseneu. 1998. Proposed architecture for lecithin:cholesterol acyltransferase. Identification of the catalytic triad and molecular modeling of LCAT. Protein Sci. 7: 587-599.
14. Blanco-Vaca, F., S. J. Qu, C. Fiol, H. Z. Fan, Q. Pao, C. A. Marzal, J. J. Albers, I. Hurtado, V. Gracia, X. Pinto, T. Marti, and H. J. Pownall. 1997. Molecular basis of fish-eye disease in a patient from Spain. Characterization of a novel mutation in the LCAT gene and lipid analysis of the cornea. Arterioscler. Thromb. Vasc. Biol. 17: 1382-1391.
15. Duverger N., H. Klein, G. Luc, J. Fruchart, J. Albers, H. Brewer, and S. Santamarina-Fojo. 1993. Identification of a novel mutation in the LCAT gene resulting in fish eye disease with α-LCAT activity. Circulation. 88:1-423 #2274. (Abstract).
16. Elkhalil L., Z. Majd, R. Bakir, O. Perez-Mendez, G. Castro, P. Poulain, B. Lacroix, N. Duhal, J. Fruchart, and G. Luc. 1997. Fish-eye disease: structural and in vivo metabolic abnormalities of high-density lipoproteins. Metabolism. 46: 474-483.
17. Wilson, R., R. Ainscough, K. Anderson, C. Baynes, M. Berks, J. Bonfield, J. Burton, M. Connell, T. Copsey, and J. Cooper. 1994. 2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans. Nature. 368: 32-38.
18. Verhasselt, P., R. Aert, M. Vet, and G. Volckaert. 1994. Twelve open reading frames revealed in the 23.6 kb segment flanking the centromere on the Saccharomyces ceomosome XIV right arm. Yeast. 10: 1355-1361.
19. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22: 4673-4680.
20. Livingstone, C. D., and G. J. Barton. 1993. Protein sequence alignments: a strategy for the hierarchical analysis of residue conservation. Comput. Appl. Biosci. 9: 745-756.
21. Barton, G. J. 1993: ALSCRIPT: a tool to format multiple sequence alignments. Protein Eng. 6: 37-40.
22. Ollis, D. L., E. Cheah, M. Cygler, B. Dijkstra, F. Frolow, S. Franken, M. Harel, S. J. Remington, I. Silman, J. Schrag, J. L. Sussman, K. H. G. Verschueren, and A. Goldman. 1992. The α/β hydrolase fold. Protein Eng. 5: 197-211.
23. Winkler, F. K., A. d'Arcy, and W. Hunzinker. 1990. Structure of human pancreatic lipase. Nature. 343: 771-774.
24. Hide, W. A. L. Chan, and W. H. Li. 1992. Structure and evolution of the lipase superfamily. J. Lipid Res. 33: 167-178.
25. Wang, J. C., A. K. Gebre, R. A. Anderson, and J. S. Parks. 1997. Amino acid residue 149 of lecithin:cholesterol acyltransferase determines phospholipase A(2) and transacylase fatty acyl specificity. J. Biol. Chem. 272: 280-286.
26. Francone, O., L. Evangelista, and C. Fielding. 1996. Effects of carboxy-terminal truncation on human lecithin:cholesterol acyltransferase activity. J. Lipid Res. 37: 1609-1615.
27. McLean, J. 1992. Molecular defects in the lecithin:cholesterol acyltransferase gene. In High Density Lipoproteins and Atherosclerosis III. N. E. Miller and A. Tall, editors. Excerpta Medica, Amsterdam. 59-65.
28. Funke, H., A. von Eckardstein, P. H. Pritchard, A. E. Hornby, H. Wiebusch, C. Motti, M. R. Hayden, C. Dachet, B. Jacotot, U. Gerdes, O. Faergeman, J. J. Albers, N. Colleoni, A. Catapano, J. Frohlich, G. Assmann, M. Kleingunnewigk, and A. Reckwerth. 1993. Genetic and phenotypic heterogeneity in familial lecithin:cholesterol acyltransferase (LCAT) deficiency - 6 newly identified defective alleles further contribute to the structural heterogeneity in this disease. J. Clin. Invest. 91: 677-683.
29. Guérin, M., P. J. Dolphin, and M. J. Chapman. 1993. Familial lecithin:cholesterol acyltransferase deficiency: further resolution of lipoprotein particle heterogeneity in the low density interval. Atherosclerosis. 104: 195-212.
30. Dorval, I., P. Jezequel, C. Dubourg, B. Chauvel, P. Le Pogamp, and J. Le Gall. 1994. Identification of the homozygous missense mutation in the lecithin:cholesterol-acyltransferase (LCAT) gene, causing LCAT familial deficiency in two French patients. Atherosclerosis. 105: 251-252.
31. Hill, J. S. 1994. The molecular pathology of lecithin:cholesterol acyltransferase deficiency. PHD Dissertation.
32. Qu, S. J., H. Z. Fan, F. Blanco-Vaca, and H. J. Pownall. 1995. In vitro expression of natural mutants of human lecithin:cholesterol acyltransferase. J. Lipid Res. 36: 967-974.
33. 344 → Ser). J. Lipid. Res. 36: 2329-2343.
34. Klein, H. G., P. Lohse, P. H. Pritchard, D. Bojanovski, H. Schmidt, and H. B. Brewer, Jr. 1992. Two different allelic mutations in the lecithin:cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin:cholesterol acyltransferase (Thr123→Ile) and lecithin:cholesterol acyltransferase (Thr347→Met). J. Clin. Invest. 89: 499-506.
35. Klein, H. G., N. Duverger, J. J. Albers, S. Marcovina, H. B. Brewer, and S. Santamarina-Fojo. 1995. In vitro expression of structural defects in the lecithin:cholesterol acyltransferase gene. J. Biol. Chem. 270: 9443-9447.
36. Yang, X., A. Inazu, A. Honjo, I. Koizumi, K. Kajinami, J. Koizumi, S. Marcovina, J. Albers, and H. Mabuchi. 1997. Gatalytically inactive lecithin:cholesterol acyltransfcrase (LCAT) caused by a Gly 30 to Ser mutation in a family with LCAT deficiency. J. Lipid Res. 38: 585-591.
37. Wiebusch, H., P. Cullen, J. S. Owen, D. Collins, P. S. Sharp, H. Funke, and G. Assmann. 1995. Deficiency of lecithin:cholesterol acyltransferasc due to compound heterozygosity of two novel mutations (Gly33Arg and 30 bp ins) in the LCAT gene. Hum. Mol. Genet. 4: 143-145.
38. Jauhiainen, M., K. J. Stevenson, and P. J. Dolphin. 1988. Human plasma lecithin:cholesterol acyltransferase. The vicinal nature of cysteine 31 and cysteine 184 in the catalytic site. J. Biol. Chem. 263: 6525-6533.
39. Taramelli, R., M. Pontoglio, G. Candiani, S. Ottolenghi, H. Dieplinger, A. Catapano, J. Albers, C. Vergani, and J. McLean. 1990. Lecithin:cholesterol acyltransferase deficiency: molecular analysis of a mutated allele. Hum. Genet. 85: 195-199.
40. 156→asn). J. Lipid Res. 34: 49-58.
41. Peelman, F., Goethals, M. Vanloo, B. Brasseur, R. Vandekerckhove, J. and M. Rosseneu. 1997. Structural and functional properties of WT and variant peptides of the 154-171 segment of lecithin:cholesterol acyltransferase. Eur. J. Biochem. 249: 708-715.
42. Hill, J. S., X. Wang, and P. H. Pritchard. 1993. Lecithin:cholesterol acyltransferase deficiency: identification of a causative gene mutation and a co-inherited protein polymorphism. Biochim. Biophys. Acta. 1181: 321-323.
43. Kuivenhoven, J. A., A. F. H. Stalenhoef, J. S. Hill, P. N. M. Demacker, A. Errami, J. J. P. Kastelein, and P. H. Pritchard. 1996. Two novel molecular defects in the LCAT gene are associated with fish eye disease. Arterioscler. Thromb. Vasc. Biol. 16: 294-303.
44. Steyrer, E., S. Haubenwallner, G. Horl, W. Giessauf, G. M. Kostner, and R. Zechner. 1995. A single G to A nucleotide transition in exon IV of the lecithin:cholesterol acyltransferase (LCAT) gene results in an Arg140 to His substitution and causes LCAT-deficiency. Hum. Genet. 96: 105-109.
45. Funke, H., A. Von Eckardstein, P. H. Pritchard, J. J. Albers, J. J. P. Kastelein, C. Drought, and G. Assmann. 1991. A molecular defect causing fish eye disease: an amino acid exchange in lecithin:cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity. Proc. Natl. Acad. Sci. USA 88: 413-419.
46. Contacos, C., D. R. Sullivan, K-A. Rye, H. Funke, and G. Assmann. 1996. A new molecular defect in the lecithin:cholesterol acyltransferase (LCAT) gene associated with fish eye disease. J. Lipid Res. 37: 35-44.
47. 123→Ile mutation esterifies cholesterol in low density lipoprotein but not in high density lipoprotein. J. Lipid Res. 34: 81-88.
48. Kuivenhoven, J. A., E. J. van Voorst tot Voorst, H. Wiebusch, S. M. Marcovina, H. Funke, G. Assmann, P. H. Pritchard, and J. J. Kastelein. 1995. A unique genetic and biochemical presentation of fish-eye disease. J. Clin. Invest. 96: 2783-2791.
49. Frohlich, J., G. R. Hoag, M. McLeod, D. V. Hayden, L. D. Godin, J. D. Wadworth, S. Crichley, and P. H. Pritchard. 1987. Hypoalphalipoproteinemia resembling fish eye disease. Acta Med. Scand. 221: 291-298.
50. Skretting, G., J. P. Blomhoff, J. Solheim, and H. Prydz. 1992. The genetic defect of the original Norwegian lecithin:cholesterol acyltransferase deficiency families. FEBS Lett. 309: 307-310.
51. Skretting, G., and H. Prydz. 1992. An amino acid exchange in exon 1 of the human lecithin:cholesterol acyltransferase (LCAT) gene is associated with fish eye disease. Biochem. Biophys. Res. Commun. 182: 583-587.
52. Klein, H. G., S. Santamarina-Fojo, N. Duverger, M. Clerc, M. F. Dumon, J. J. Albers, S. Marcovina, and H. B. Brewer. 1993. Fish eye syndrome - a molecular defect in the lecithin:cholesterol acyltransferase (LCAT) gene associated with normal alpha-LGAT-specific activity - implications for classification and prognosis. J. Clin. Invest. 92: 479-485.
53. Derewenda, Z. S., and C. Cambillau. 1991. Effects of gene mutations in lipoprotein and hepatic lipases as interpreted by a molecular model of the pancreatic triglyceride lipase. J. Biol. Chem. 266: 23112-23119.